Selected research
Market Structure
Global Neonatal Immune Cell Storage Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Neonatal Immune Cell Storage Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Neonatal Immune Cell Storage Service include Shanghai Cell Therapy Group, BGI Group, VCANBIO, CGT GLOBAL, Cordlife Group, ThermoGenesis, HealthBanks, BioLife Solutions and Sartorius, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Neonatal Immune Cell Storage Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Neonatal Immune Cell Storage Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Neonatal Immune Cell Storage Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Neonatal Immune Cell Storage Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Neonatal Immune Cell Storage Service Segment by Company
Shanghai Cell Therapy Group
BGI Group
VCANBIO
CGT GLOBAL
Cordlife Group
ThermoGenesis
HealthBanks
BioLife Solutions
Sartorius
CGT GLOBAL
Cordlife Group
Aeterna Health
Cell Vault
Redermis
Innovita Research
Neonatal Immune Cell Storage Service Segment by Type
100ml Blood Collection Volume
150ml Blood Collection Volume
200ml Blood Collection Volume
Neonatal Immune Cell Storage Service Segment by Application
Personal
Commercial
Neonatal Immune Cell Storage Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neonatal Immune Cell Storage Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neonatal Immune Cell Storage Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neonatal Immune Cell Storage Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Neonatal Immune Cell Storage Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neonatal Immune Cell Storage Service industry.
Chapter 3: Detailed analysis of Neonatal Immune Cell Storage Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neonatal Immune Cell Storage Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100ml Blood Collection Volume
- 150ml Blood Collection Volume
- 200ml Blood Collection Volume
Applications
- Personal
- Commercial
Companies covered
- Shanghai Cell Therapy Group
- BGI Group
- VCANBIO
- CGT GLOBAL
- Cordlife Group
- ThermoGenesis
- HealthBanks
- BioLife Solutions
- Sartorius
- CGT GLOBAL
- Cordlife Group
- Aeterna Health
- Cell Vault
- Redermis
- Innovita Research
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Neonatal Immune Cell Storage Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 100ml Blood Collection Volume
- 1.2.3 150ml Blood Collection Volume
- 1.2.4 200ml Blood Collection Volume
- 1.3 Market Analysis by Application
- 1.3.1 Global Neonatal Immune Cell Storage Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Personal
- 1.3.3 Commercial
- 1.4 Global Market Growth Prospects
- 1.5 Global Neonatal Immune Cell Storage Service Growth Trends by Region
- 1.5.1 Global Neonatal Immune Cell Storage Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Neonatal Immune Cell Storage Service Market Size by Region (2021-2026)
- 1.5.3 Neonatal Immune Cell Storage Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Neonatal Immune Cell Storage Service Market Dynamics
- 2.1 Neonatal Immune Cell Storage Service Industry Trends
- 2.2 Neonatal Immune Cell Storage Service Industry Drivers
- 2.3 Neonatal Immune Cell Storage Service Industry Opportunities and Challenges
- 2.4 Neonatal Immune Cell Storage Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Neonatal Immune Cell Storage Service Revenue by Company (2021-2026)
- 3.2 Global Neonatal Immune Cell Storage Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Neonatal Immune Cell Storage Service Key Company Head office and Area Served
- 3.4 Global Neonatal Immune Cell Storage Service Company, Product Type & Application
- 3.5 Global Neonatal Immune Cell Storage Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Neonatal Immune Cell Storage Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Neonatal Immune Cell Storage Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Neonatal Immune Cell Storage Service Tier 1, Tier 2, and Tier 3
4 Neonatal Immune Cell Storage Service Market by Type
- 4.1 Global Neonatal Immune Cell Storage Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Neonatal Immune Cell Storage Service Market Size by Type (2021-2032)
- 4.3 Global Neonatal Immune Cell Storage Service Market Size Share by Type (2021-2032)
5 Neonatal Immune Cell Storage Service Market by Application
- 5.1 Global Neonatal Immune Cell Storage Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Neonatal Immune Cell Storage Service Market Size by Application (2021-2032)
- 5.3 Global Neonatal Immune Cell Storage Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Shanghai Cell Therapy Group
- 6.1.1 Shanghai Cell Therapy Group Company Information
- 6.1.2 Shanghai Cell Therapy Group Business Overview
- 6.1.3 Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Product Portfolio
- 6.1.5 Shanghai Cell Therapy Group Recent Developments
- 6.2 BGI Group
- 6.2.1 BGI Group Company Information
- 6.2.2 BGI Group Business Overview
- 6.2.3 BGI Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 BGI Group Neonatal Immune Cell Storage Service Product Portfolio
- 6.2.5 BGI Group Recent Developments
- 6.3 VCANBIO
- 6.3.1 VCANBIO Company Information
- 6.3.2 VCANBIO Business Overview
- 6.3.3 VCANBIO Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 VCANBIO Neonatal Immune Cell Storage Service Product Portfolio
- 6.3.5 VCANBIO Recent Developments
- 6.4 CGT GLOBAL
- 6.4.1 CGT GLOBAL Company Information
- 6.4.2 CGT GLOBAL Business Overview
- 6.4.3 CGT GLOBAL Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
- 6.4.5 CGT GLOBAL Recent Developments
- 6.5 Cordlife Group
- 6.5.1 Cordlife Group Company Information
- 6.5.2 Cordlife Group Business Overview
- 6.5.3 Cordlife Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
- 6.5.5 Cordlife Group Recent Developments
- 6.6 ThermoGenesis
- 6.6.1 ThermoGenesis Company Information
- 6.6.2 ThermoGenesis Business Overview
- 6.6.3 ThermoGenesis Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 ThermoGenesis Neonatal Immune Cell Storage Service Product Portfolio
- 6.6.5 ThermoGenesis Recent Developments
- 6.7 HealthBanks
- 6.7.1 HealthBanks Company Information
- 6.7.2 HealthBanks Business Overview
- 6.7.3 HealthBanks Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 HealthBanks Neonatal Immune Cell Storage Service Product Portfolio
- 6.7.5 HealthBanks Recent Developments
- 6.8 BioLife Solutions
- 6.8.1 BioLife Solutions Company Information
- 6.8.2 BioLife Solutions Business Overview
- 6.8.3 BioLife Solutions Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 BioLife Solutions Neonatal Immune Cell Storage Service Product Portfolio
- 6.8.5 BioLife Solutions Recent Developments
- 6.9 Sartorius
- 6.9.1 Sartorius Company Information
- 6.9.2 Sartorius Business Overview
- 6.9.3 Sartorius Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Sartorius Neonatal Immune Cell Storage Service Product Portfolio
- 6.9.5 Sartorius Recent Developments
- 6.10 CGT GLOBAL
- 6.10.1 CGT GLOBAL Company Information
- 6.10.2 CGT GLOBAL Business Overview
- 6.10.3 CGT GLOBAL Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
- 6.10.5 CGT GLOBAL Recent Developments
- 6.11 Cordlife Group
- 6.11.1 Cordlife Group Company Information
- 6.11.2 Cordlife Group Business Overview
- 6.11.3 Cordlife Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
- 6.11.5 Cordlife Group Recent Developments
- 6.12 Aeterna Health
- 6.12.1 Aeterna Health Company Information
- 6.12.2 Aeterna Health Business Overview
- 6.12.3 Aeterna Health Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Aeterna Health Neonatal Immune Cell Storage Service Product Portfolio
- 6.12.5 Aeterna Health Recent Developments
- 6.13 Cell Vault
- 6.13.1 Cell Vault Company Information
- 6.13.2 Cell Vault Business Overview
- 6.13.3 Cell Vault Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Cell Vault Neonatal Immune Cell Storage Service Product Portfolio
- 6.13.5 Cell Vault Recent Developments
- 6.14 Redermis
- 6.14.1 Redermis Company Information
- 6.14.2 Redermis Business Overview
- 6.14.3 Redermis Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Redermis Neonatal Immune Cell Storage Service Product Portfolio
- 6.14.5 Redermis Recent Developments
- 6.15 Innovita Research
- 6.15.1 Innovita Research Company Information
- 6.15.2 Innovita Research Business Overview
- 6.15.3 Innovita Research Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Innovita Research Neonatal Immune Cell Storage Service Product Portfolio
- 6.15.5 Innovita Research Recent Developments
7 North America
- 7.1 North America Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 7.2 North America Neonatal Immune Cell Storage Service Market Size by Type
- 7.2.1 North America Neonatal Immune Cell Storage Service Market Size by Type (2021-2026)
- 7.2.2 North America Neonatal Immune Cell Storage Service Market Size by Type (2027-2032)
- 7.2.3 North America Neonatal Immune Cell Storage Service Market Share by Type (2021-2032)
- 7.3 North America Neonatal Immune Cell Storage Service Market Size by Application
- 7.3.1 North America Neonatal Immune Cell Storage Service Market Size by Application (2021-2026)
- 7.3.2 North America Neonatal Immune Cell Storage Service Market Size by Application (2027-2032)
- 7.3.3 North America Neonatal Immune Cell Storage Service Market Share by Application (2021-2032)
- 7.4 North America Neonatal Immune Cell Storage Service Market Size by Country
- 7.4.1 North America Neonatal Immune Cell Storage Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 7.4.3 North America Neonatal Immune Cell Storage Service Market Size by Country (2027-2032)
- 7.4.4 North America Neonatal Immune Cell Storage Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 8.2 Europe Neonatal Immune Cell Storage Service Market Size by Type
- 8.2.1 Europe Neonatal Immune Cell Storage Service Market Size by Type (2021-2026)
- 8.2.2 Europe Neonatal Immune Cell Storage Service Market Size by Type (2027-2032)
- 8.2.3 Europe Neonatal Immune Cell Storage Service Market Share by Type (2021-2032)
- 8.3 Europe Neonatal Immune Cell Storage Service Market Size by Application
- 8.3.1 Europe Neonatal Immune Cell Storage Service Market Size by Application (2021-2026)
- 8.3.2 Europe Neonatal Immune Cell Storage Service Market Size by Application (2027-2032)
- 8.3.3 Europe Neonatal Immune Cell Storage Service Market Share by Application (2021-2032)
- 8.4 Europe Neonatal Immune Cell Storage Service Market Size by Country
- 8.4.1 Europe Neonatal Immune Cell Storage Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 8.4.3 Europe Neonatal Immune Cell Storage Service Market Size by Country (2027-2032)
- 8.4.4 Europe Neonatal Immune Cell Storage Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 9.2 China Neonatal Immune Cell Storage Service Market Size by Type
- 9.2.1 China Neonatal Immune Cell Storage Service Market Size by Type (2021-2026)
- 9.2.2 China Neonatal Immune Cell Storage Service Market Size by Type (2027-2032)
- 9.2.3 China Neonatal Immune Cell Storage Service Market Share by Type (2021-2032)
- 9.3 China Neonatal Immune Cell Storage Service Market Size by Application
- 9.3.1 China Neonatal Immune Cell Storage Service Market Size by Application (2021-2026)
- 9.3.2 China Neonatal Immune Cell Storage Service Market Size by Application (2027-2032)
- 9.3.3 China Neonatal Immune Cell Storage Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 10.2 Asia Neonatal Immune Cell Storage Service Market Size by Type
- 10.2.1 Asia Neonatal Immune Cell Storage Service Market Size by Type (2021-2026)
- 10.2.2 Asia Neonatal Immune Cell Storage Service Market Size by Type (2027-2032)
- 10.2.3 Asia Neonatal Immune Cell Storage Service Market Share by Type (2021-2032)
- 10.3 Asia Neonatal Immune Cell Storage Service Market Size by Application
- 10.3.1 Asia Neonatal Immune Cell Storage Service Market Size by Application (2021-2026)
- 10.3.2 Asia Neonatal Immune Cell Storage Service Market Size by Application (2027-2032)
- 10.3.3 Asia Neonatal Immune Cell Storage Service Market Share by Application (2021-2032)
- 10.4 Asia Neonatal Immune Cell Storage Service Market Size by Country
- 10.4.1 Asia Neonatal Immune Cell Storage Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 10.4.3 Asia Neonatal Immune Cell Storage Service Market Size by Country (2027-2032)
- 10.4.4 Asia Neonatal Immune Cell Storage Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Neonatal Immune Cell Storage Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst